Sichenzia Ross Ference represented Aegis Capital Corp. as sole book runner in the initial public offering.
The offering was priced at $5.51 per unit, each consisting of one ordinary share and one warrant to purchase one ordinary share, with an initial exercise price of $5.50 per share. The ordinary shares and warrants are trading on NASDAQ under the symbols “IINN” and “IINNW”, respectively.
In addition, the Company granted Aegis Capital Corp. a 45-day option to purchase up to 436,363 additional ordinary shares and/or 436,363 warrants to purchase 436,363 ordinary shares at the public offering price to cover over-allotments. The underwriter partially exercised its over-allotment option with respect to 436,363 warrants to purchase ordinary shares.
Inspira Technologies OXY B.H.N. Ltd is an Israeli specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology.
The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia (Picture), Darrin M. Ocasio, Avital Perlman and Jeffrey Cahlon.
Law Firms: Sichenzia Ross Ference;
Clients: Aegis Capital Corporation;